Assura (AGR) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
6 Jun, 2025Assura plc: unique portfolio and platform
Portfolio exceeds £3bn with a 13-year WAULT and 99% occupancy, over 90% of rent from NHS or tier 1 healthcare operators.
Delivers a 7.7% dividend yield and 7% dividend CAGR over 10 years, with an A- investment grade rating and >100% dividend cover.
Rent roll has doubled since 2018, with substantial growth in private tenant weighting and a strong track record of quality portfolio additions.
Active capital recycling, with £200m recycled this year and a focus on accretive opportunities and efficient portfolio management.
Strong balance sheet with net debt to EBITDA below 9x, fixed average interest rate of 3%, and 80% of debt maturing beyond 2028.
Market opportunity and growth drivers
UK healthcare faces rising demand due to an ageing population and increasing per capita costs, with 17% of the population over 70 by 2040.
NHS maintenance backlog has more than doubled in a decade, requiring significant investment to ensure fit-for-purpose facilities.
Community healthcare is key to affordable delivery, with a 6% CAGR in private market revenues and a push to move services out of hospitals.
National imperative to reduce waiting times, as waiting lists and median wait times have risen sharply.
Political environment supports private sector involvement, with NHS and independent sector partnerships and a forthcoming 10-year NHS plan.
Competitive advantages and financial performance
Assura offers a strong return over gilts, with a current spread of c.440bps over UK 10-year gilts and c.800bps over index-linked gilts.
Portfolio is uniquely diversified across GP medical centres, NHS facilities, and independent hospitals, each with 10% estimated market share.
Long-term relationships, specialist market knowledge, and full property offering create barriers to entry and access to JV capital.
Sustained growth in earnings (6.2% CAGR) and dividends (7.3% CAGR) since 2015, with 11 consecutive years of dividend increases.
Efficient flow of rental growth to earnings and dividends, with a low EPRA cost ratio (12%) and scope for further efficiency.
Latest events from Assura
- Strong quarter with new JV, dividend hike, and focus on NHS/private growth amid inflation challenges.AGR
AGM 20243 Feb 2026 - £500m hospital acquisition accelerates diversification, boosts returns, and supports long-term growth.AGR
M&A Announcement (Q&A)2 Feb 2026 - £500m acquisition of 14 UK private hospitals accelerates diversification and earnings growth.AGR
M&A Announcement2 Feb 2026 - £500m hospital deal, 8% rental growth, and asset disposals drive robust outlook.AGR
H1 202514 Jan 2026 - £500m hospital acquisition, JV launch, and rental growth drive robust returns and portfolio strength.AGR
H2 202521 Jul 2025 - £500m private hospital acquisition and joint venture drive growth and diversification.AGR
Trading Update13 Jun 2025 - Assura advances growth with a major joint venture, new developments, and a dividend increase.AGR
Trading Update13 Jun 2025 - Assura's portfolio value rose to £3.1bn with strong rent growth and enhanced ESG credentials.AGR
Trading Update6 Jun 2025 - Q3 saw portfolio growth, debt reduction, and a 9.3% dividend yield, underpinned by policy support.AGR
Trading Update6 Jun 2025